TTALO — Terveystalo Oyj Balance Sheet
0.000.00%
- €1.51bn
- €2.01bn
- €1.34bn
- 95
- 54
- 100
- 98
Annual balance sheet for Terveystalo Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 77.1 | 38.1 | 40.2 | 42.5 | 68.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 90.5 | 121 | 126 | 135 | 120 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 179 | 173 | 190 | 193 | 208 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 240 | 245 | 256 | 296 | 270 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,361 | 1,449 | 1,479 | 1,420 | 1,398 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 303 | 398 | 317 | 300 | 320 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 790 | 840 | 887 | 904 | 850 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 571 | 609 | 592 | 515 | 548 |
Total Liabilities & Shareholders' Equity | 1,361 | 1,449 | 1,479 | 1,420 | 1,398 |
Total Common Shares Outstanding |